Insider Buying: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) CFO Purchases 15,000 Shares of Stock
MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) CFO Anna Mowry purchased 15,000 shares of Nautilus Biotechnology stock in a transaction dated Thursday, May 29th. The shares were purchased at an average cost of $0.77 per share, with a total value of $11,550.00. Following the acquisition, the chief financial officer now owns 83,000 shares of the company's stock, valued at approximately $63,910. This trade represents a 22.06% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
NASDAQ:NAUT
